Clomipramine-induced mood and perceived performance changes in selected healthy individuals [11]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 3, 2007, Pages 314-315

  Gentil, Valentim ^a   Zilberman, Monica L ^a   Lobo, Daniela ^a   Henna, Elaine ^a   Moreno, Ricardo A ^a   Gorenstein, Clarice ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; PLACEBO;

CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DECISION MAKING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; EMOTION; HUMAN; HUMAN EXPERIMENT; IRRITABILITY; LETTER; LOW DRUG DOSE; MENTAL PERFORMANCE; MENTAL STRESS; MOOD CHANGE; NORMAL HUMAN; PARALLEL DESIGN; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITATIVE ANALYSIS; RATING SCALE; SELF ESTEEM; SEMI STRUCTURED INTERVIEW; SINGLE BLIND PROCEDURE; SOCIAL INTERACTION; VARIANCE;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS; CLOMIPRAMINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PROPANTHELINE;

EID: 34248597908     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000270084.15253.5c     Document Type: Letter

References (8)

1. Knutson B, Wolkowitz OM, Cole SW, et al. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry. 1998;155:373-379.
2. Andrews W, Parker G, Barrett E. The SSRI antidepressants: exploring their "other" possible properties. J Affect Disord. 1998;49:141-144.
3. Gorenstein C, Gentil V, Melo M, et al. Mood improvement in "normal" volunteers. J Psychopharmacol. 1998;12:246-251.
4. Gentil V, Lotufo-Neto F, Andrade L, et al. Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine. J Psychopharmacol. 1993;7:316-324.
5. Harmer CJ, Shelley NC, Cowen PJ, et al. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry. 2004;161:1256-1263.
6. Flory JD, Manuck SB, Matthews KA, et al. Serotonergic function in the central nervous system is associated with daily ratings of positive mood. Psychiatry Res. 2004;129:11-19.
7. Tse WS, Bond AJ. Reboxetine promotes social bonding in healthy volunteers. J Psychopharmacol. 2003;17:189-195.
8. Weissman MM, Wickramaratne P, Adams P, et al. Brief screening for family psychiatric history: the family history screen. Arch Gen Psychiatry. 2000;57:675-682.